Adverse Maternal Fetal Environment Partially Mediates Disparate Outcomes in Non-White Neonates with Major Congenital

Stephanie Santana1, Shabnam Peyvandi2, John M Costello1

  • 1Department of Pediatrics, Division of Cardiology, Shawn Jenkins Children's Hospital, Medical University of South Carolina, Charleston, SC.

Insights

Adverse maternal conditions contribute to racial disparities in infant congenital heart disease (CHD) outcomes. These environmental factors partially explain why minority infants with CHD face worse results and fewer days alive.

Area of Science:

  • Perinatal health
  • Pediatric cardiology
  • Health disparities research

Background:

  • Infants with congenital heart disease (CHD) exhibit significant racial and ethnic outcome disparities.
  • The role of the maternal-fetal environment in these disparities remains incompletely understood.

Purpose of the Study:

  • To investigate if differential exposure to adverse maternal-fetal environments contributes to disparate outcomes in infants with major congenital heart disease (CHD).

Main Methods:

  • A retrospective cohort study analyzed a California population-based database (2011-2017).
  • Race/ethnicity was the primary exposure, with adverse maternal-fetal environment (maternal metabolic syndrome and/or maternal placental syndrome) as the mediator.
  • Outcomes included a composite of 1-year mortality or severe morbidity and days alive out of hospital (DAOOH).

Main Results:

  • Hispanic and non-Hispanic Black infants had higher risks for the composite outcome and fewer DAOOH compared to non-Hispanic White infants.
  • These minority groups showed increased exposure to maternal metabolic syndrome and/or maternal placental syndrome.
  • Adverse maternal-fetal environment explained 16-25% of the racial/ethnic disparities in CHD outcomes.

Conclusions:

  • Increased exposure to adverse maternal-fetal environments significantly contributes to racial and ethnic disparities observed in major congenital heart disease outcomes.
  • Addressing maternal health factors is crucial for mitigating outcome inequities in infants with CHD.
Abstract

Related Concept Videos

Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
1.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K